Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic Radiofrequency

Recruiting now

Conditions studied: Pancreatic Tumor

In brief

The purpose of the study is to evaluate the oncological efficacy of pancreatic radiofrequency by the objective response rate (complete and partial responses according to RECIST 1.1.), 5 years after the end of treatment.

Key facts

Study ID

NCT05871164

Run by

GCS Ramsay Santé pour l'Enseignement et la Recherche

People needed

200

Starts

2023-06-12

Expected to finish

2030-05-01

Last updated by the study team

2026-04-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years old;
• Patient to be treated for a pancreatic tumor by ultrasound-guided RF with a fine needle;
• Indication of pancreatic radiofrequency validated in a Multidisciplinary Consultation Meeting;
• Patient able to understand the information related to the study;
• Patient accepting study follow-up visits;
• Patient having been informed and agreeing to participate in the study.

You may not qualify if…

• Patient with a contraindication to radiofrequency treatment;
• Pregnant or breastfeeding women

Where it is running

• CHI Toulon La Seyne — Toulon, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.